流通產業發展에 있어서의 政府의 役割

南旭 한국마케팅연구원 1983 마케팅 Vol.17 No.6

Factors associated with testosterone recovery after androgen deprivation therapy in patients with prostate cancer

남욱,최세영,유상준,류제만,이재훈,경윤수,한재현,유달산,정인갑,홍준혁,안한종,김청수 대한비뇨의학회 2018 Investigative and Clinical Urology Vol.59 No.1

Purpose: We investigated factors affecting testosterone recovery after androgen deprivation therapy (ADT) withdrawal in patients with prostate cancer. Materials and Methods: The medical records of patients who underwent radical prostatectomy with ADT were retrospectively reviewed. In all, 221 patients were included in the analysis. Testosterone recovery was defined as supra-castration (SC) (testosterone levels in serum >50 ng/dL) or out of hypogonadism (OH) (>300 ng/dL) after ADT withdrawal. Kaplan-Meier analyses were used to estimate testosterone recovery after ADT cessation. Cox regression analyses were used to determine the factors affecting the recovery of testosterone. Results: After ADT, 206 patients (93.2%) recovered to the SC level and 122 patients (55.2%) recovered to the OH level. Patients treated with ADT for ≤18 months recovered to OH in a mean of 6.8 months (74.6%), but patients treated with ADT for >18 months recovered in a mean of 9.7 months (27.5%). In multivariate analyses, age (hazard ratio [HR], 0.915; p<0.001), serum level of sex hormone-binding globulin (SHBG) (HR, 1.015; p=0.002), initial testosterone level (HR, 1.002; p=0.002), and ADT duration (HR, 0.915; p<0.001) were associated with recovery to the OH level after ADT withdrawal, and hypertension (HR, 0.697; p=0.029) and duration of ADT (HR, 0.979; p=0.012) were significantly associated with recovery to SC. Conclusions: In patients treated with ADT for ≤18 months, testosterone recovers to the OH level more often and faster after ADT cessation. Age, SHBG level, initial testosterone level, and ADT duration are associated with testosterone recovery.

근관형성 후 동통에 대한 수산화칼슘의 효과에 관한 연구

남욱,박상혁,최기운 大韓齒科保存學會 2006 Restorative Dentistry & Endodontics Vol.31 No.2

본 연구는 치성 동통을 보이는 치아의 수산화칼숨의 사용 여부에 따른 동통 감소 효과를 판단하고자 시행하였다. 2003년 12월부터 2004년 9월 사이에 경희대학교 치과대학 부속 치과병원 치과보존과에 치성 동통으로 내원한 환자 213명으로부터 근관형성을 시행한 237개의 치아를 대상으로 환자의 성별 및 연령, 치료부위, 재근관 치료의 여부, 치수의 상태, 술전 치아 상태와 술전 동통의 정도를 기록하였다. 수산화칼슘을 적용하지 않은 군 (1군)과 수산화칼슘을 적용한 군 (2군)으로 분류하였다. 환자들에게 설문지를 배분하여 다음 내원시 치료 후 4시간, 2일 및 7일에 술후 동통의 발생 여부와 동통의 정도를 기록하도록 하였다. 수집한 자료들은 Chi-square analysis (p<0.05)를 사용하여 비교, 분석한 결과 근관내 약제로써 수산화칼슘은 술후 동통을 예방하거나 감소시키는 효과를 가지고 있지 않다는 것을 알 수 있었다. The purpose of this clinical study is to assess whether calcium hydroxide as an intracanal medication affects post-treatment pain in teeth especially odontogenic pain which comes from inflammation of the pulp and periradicular tissues when compared with no intracanal medication. From 213 patients who has been treated 237 root canals due to significant pain (moderate-to-severe), we recorded their age, sex, treated tooth, degree of pain, pre-operative states of the tooth. We classified patients into 2 test group: Group 1 (not gain intracanal Ca(OH)_(2)), Group 2 (gain intracanal Ca(OH)_(2)). Through the survey from the patients, we let them write down the occurrence and degree of post-treatment pain in 4hours, 2days, 7days after treatment as none. mild, moderate or severe. The followings were evaluated: the overall incidence of flare-ups, the overall incidence of post-treatment pain in each group at each time period, the incidence of post-treatment pain in each group at each time period as related to pre-operative states of the teeth. These were compared statistically with Chi-square analysis (p < 0.05). Under the condition of this investigation, no difference was observed in the incidence of post-treat-ment pain between the two groups. Therefore, Ca(OH)_(2)as intracanal medication had no effect on preventing or decreasing the post-treatment pain.

전곡종의 자급도 높여야

남욱 한국식품산업협회 1977 좋은식품 Vol.40 No.-

세월을 더듬으며

남욱 서울대학교 경영대학 1992 經營評論 Vol.8 No.-

포스터(유전) : 포스터16 ; 다발성 골수종(MM; Multiple Myeloma)의 염색체이상 발생 빈도와 증례보고

남욱이,강유선,조은해 대한임상병리사협회 2011 임상혈액검사학회 발표자료집 Vol.13 No.1

The study of fractural behavior of repaired composite

박상순,남욱,엄아향,김덕수,최기운,최경규 大韓齒科保存學會 2010 Restorative Dentistry & Endodontics Vol.35 No.6

Objectives: This study evaluated microtensile bond strength () and short-rod fracture toughness to explain fractural behavior of repaired composite restorations according to different surface treatments. Materials and Methods: Thirty composite blocks for test and sixty short-rod specimens for fracture toughness test were fabricated and were allocated to 3 groups according to the combination of surface treatment (none-treated, sand blasting, bur roughening). Each group was repaired immediately and 2 weeks later. Twenty-four hours later from repair, and fracture toughness test were conducted. Mean values analyzed with two-way ANOVA / Tukey's B test (= 0.05) and correlation analysis was done between and fracture toughness. FE-SEM was employed on fractured surface to examine the crack propagation. Results: The fresh composite resin showed higher than the aged composite resin (p < 0.001). Mechanically treated groups showed higher bond strength than non-mechanically treated groups except none-treated fresh group in (p < 0.05). The fracture toughness value of mechanically treated surface was higher than that of non-mechanically treated surface (p < 0.05). There was no correlation between fracture toughness and microtensile bond strength values. Specimens having high KIC showed toughening mechanism including crack deviation, microcracks and crack bridging in FE-SEM. Conclusions: Surface treatment by mechanical interlock is more important for effective composite repair, and the fracture toughness test could be used as an appropriate tool to examine the fractural behavior of the repaired composite with microtensile bond strength. 연구목적: 본 연구는 미세인장결합강도와 파괴인성을 통해 복합 레진 수복물의 수리 시기와 표면 처리 방법에 따른 파괴 거동을 알아보고자 시행되었다. 연구 재료 및 방법: Short rod 시편과 composite resin specimen block을 준비하여 표면 처리 방법에 따라 none-treated, sand blasting, bur roughening 군으로 나누고 이를 다시 즉시군과 2주 지연군으로 나누어 수리했다. 결과: 미세인장결합강도와 파괴인성을 측정한 결과, 두 실험 모두에서 즉시군이 지연군보다 높은 값을 보였다. 기계적 표면 처리군이 none-treated군보다 높은 값을 보였고, sand blasting과 bur roughening 사이에 유의한 차이는 없었다. 파괴인성과 미세인장결합강도는 상관 관계가 없었다. FE-SEM을 보아 수복물의 탈락은 균열 전도와 관계가 있는 것으로 보인다. 결론: 수리된 복합 레진의 파괴 거동 평가에는 파괴인성 실험이 적합하다.

Long-term Outcomes of Endoscopic Anti-reflux Surgery in Pediatric Patients with Vesicoureteral Reflux: Urinary Tract Infection, Renal Scarring, and Predictive Factors for Success

최원석,남욱,이찬우,한재현,신정현,김건석,송상훈 대한의학회 2018 Journal of Korean medical science Vol.33 No.38

Background: To report the long-term outcomes of endoscopic surgery (ES) in pediatric patients with vesicoureteral reflux in terms of success rate, urinary tract infection, and renal function. Methods: We retrospectively reviewed the records of 73 pediatric patients (110 ureters) who underwent ES for vesicoureteral reflux. Ultrasonography was performed 1, 3, and 12 months postoperatively. Voiding cystourethrography was performed 3 months postoperatively and repeated after 1 year if vesicoureteral reflux persisted. Success was defined as the absence of reflux at the first voiding cystourethrography. Renal scans were performed at least 12 months postoperatively. Renal function deterioration was defined as a new scar or a greater than 5% decrease in function. Results: The median follow-up duration was 24 (12–118) months. The overall success was 65.6%, while it was 78.9%, 87.0%, 62.5%, 37.5%, 66.7% for grades I, II, III, IV, and V, respectively. In multivariate analyses, significant predictive factors for success were vesicoureteral reflux grade (odds ratio [OR], 0.28; P < 0.001) and mound detection at the first postoperative ultrasonography (OR, 13.53; P < 0.001). Renal function deterioration was found in 8 (15.3%) ureters and was less common in those with successful surgeries than in those with failures (9.5% vs. 40.0%; P = 0.035). No significant predictive factor for renal function deterioration or urinary tract infection was found. Conclusion: Successful short-term outcomes of ES are expected in low-grade vesicoureteral reflux, especially when a mound is detected by postoperative ultrasonography. However, unpredictable long-term renal deterioration warrants continued follow-up.

Effect of decreased renal function on poor oncological outcome after radical cystectomy

김동수,남욱,경윤수,유달산,정인갑,홍범식(Bumsik Hong),홍준혁,안한종,임범진 대한비뇨의학회 2023 Investigative and Clinical Urology Vol.64 No.4

Purpose: To evaluate the impact of preoperative renal impairment on the oncological outcomes of patients with urothelial carcinoma who underwent radical cystectomy. Materials and Methods: We retrospectively reviewed the medical records of patients with urothelial carcinoma who underwent radical cystectomy from 2004 to 2017. All patients who underwent preoperative 99mTc-diethylenetriaminepentaacetic acid renal scintigraphy (DTPA) were identified. We divided the patients into two groups according to their glomerular filtration rates (GFRs): GFR group 1, GFR≥90 mL/min/1.73 m2; GFR group 2, 60≤GFR<90 mL/min/1.73 m2. We included 89 patients in GFR group 1 and 246 patients in GFR group 2 and compared the clinicopathological characteristics and oncological outcomes between the two groups. Results: The mean time required for recurrence was 125.5±8.0 months in GFR group 1 and 85.7±7.4 months in GFR group 2 (p=0.030). The mean cancer-specific survival was 131.7±7.8 months in GFR group 1 and 95.5±6.9 months in GFR group 2 (p=0.051). The mean overall survival was 123.3±8.1 months in GFR group 1 and 79.5±6.6 months in GFR group 2 (p=0.004). Conclusions: Preoperative GFR values in the range of 60≤GFR<90 mL/min/1.73 m2 are independent prognostic factors for poor recurrence-free survival, cancer-specific survival, and overall survival in patients after radical cystectomy compared with GFR values of ≥90 mL/min/1.73 m2.

Comparison of Prognosis in Types 1 and 2 Papillary Renal Cell Carcinoma and Clear Cell Renal Cell Carcinoma in T1 Stage

이재훈,채한규,이원철,남욱,임범진,최세영,경윤수,유달산,정인갑,송채린,홍범식,홍준혁,안한종,김청수 대한비뇨기종양학회 2018 대한비뇨기종양학회지 Vol.16 No.3

Purpose: We compared subtypes of papillary renal cell carcinoma (pRCC; types 1 and 2) and clear cell renal cell carcinoma (ccRCC) in patients with T1-stage RCC to analyze the impact of the subtype on oncological outcomes. Materials and Methods: This paper reviewed 75 patients with pRCC and 252 patients with ccRCC at T1-stage from 1998–2012. Thus, we assessed the impact of subtype on oncologic outcomes among patients with T1-stage RCC. We used Kaplan-Meier analysis to estimate the overall survival and recurrence-free survival The median follow-up duration was 95 months (interquartile range, 75.4–119.3 months). Results: The 5-year recurrence-free survivals of pRCC and ccRCC were 95.4% and 97.6%, respectively. pRCC is worse than ccRCC in terms of recurrence-free survival (p=0.008) and there was no significant difference in the overall survival between pRCC and ccRCC (p=0.32). In addition, there was no significant statistical difference between type 1 pRCC and type 2 pRCC in terms of either recurrence-free survival (p=0.526) or overall survival (p=0.701). Age (hazard ratio [HR], 1.069; p<0.001) and recurrence (HR, 4.93; p<0.001) were predictors of overall survival. Only tumor size (HR, 1.071; p=0.004) was predictors in the case of cancer specific survival in the multivariate analysis. Conclusions: Among patients with T1-stage RCC, recurrence after surgery was more common in pRCC than ccRCC. The subtype of pRCC (types 1 and 2) had no impact on the recurrence-free survival or overall survival.